Open and available for virtual telehealth and in-person appointments. Book Now!

Using Melatonin to Fight COVID-19 | Part 2

Last week, I discussed the rationale for using melatonin based on what we know about how COVID-19 infections wreak havoc on the body’s tissues.

This week and next, I want to focus specifically on it’s anti-inflammatory, anti-oxidative, and immunomodulatory role in health and wellbeing. I will also dive into how to put all of this into practice, as well as other supportive adjuvant agents. Because I’m spending almost a month on this topic, it tells you how important I think it is!

How Melatonin Works

Melatonin possesses anti-inflammatory action through various pathways. Let’s start with Sirtuin-1, which is a member of a protein family that functions in the cellular response to inflammatory, metabolic, and oxidative stressors. If your body senses danger, Sirtuin-1 (or SIRT1) is activated and goes in to assess the chemical damage.

SIRT1 is one of the hallmark proteins in the body; it engages with your mitochondria and regulates the expression of genes key for ATP generation and proliferation. SIRT1 also increases mitochondrial biogenesis—the process by which cells increase mitochondrial mass—, thereby contributing to increased healthy life-span and reducing aging-related diseases (Yuan et al., 2016). It’s a protein you want hanging around, especially if you have increased inflammation!

This protein appears to mediate the anti-inflammatory effect of melatonin by inhibiting a protein called HMG-1 (or high-mobility group box 1 protein), which is secreted by immune cells like macrophages, monocytes, and dendritic cells. HMG-1 is a nuclear protein that organizes the DNA and regulates transcription (Klune et al., 2008). Thus, SIRT1, with the help of melatonin, downregulates the polarization of macrophages towards the pro-inflammatory type (Hardeland, 2018).

In sepsis-induced acute lung injury (ALI), the “proper” regulation of SIRT1 reduces lung injury and inflammation, and the application of melatonin adds to the therapeutic effect of SIRT1 (Wang et al., 2019). We know that SIRT1 plays a key role in chronic inflammation, and its expression and protein levels are reduced in several common (and chronic) inflammatory diseases in the U.S., including arterial inflammation, obesity, and Alzheimer’s disease (Hadar et al., 2017)

Nuclear factor kappa-B (NF-κB) is another essential pathway, and if there is anything you take away from this blog (besides the benefit of melatonin), it’s that we want to turn off NF-κB as much as we possibly can.

Granted, the influence that NF-κB has on cell survival is an ever-evolving story; it can be neuroprotective or proinflammatory, depending on cell type, developmental stage, and pathological state (Qin et al., 2007), but this is beyond the scope of this post. For this discussion, NF-κB is generally (and closely) associated with pro-inflammatory and pro-oxidative responses, while at the same time being an inflammatory mediator in ALI. The anti-inflammatory effect of melatonin involves the suppression of NF-κB activation in acute respiratory distress syndrome (ARDS) (Sun et al., 2015; Ling et al., 2018). Melatonin downregulates NF-κB activation in T cells and lung tissue (Shang et al., 2009; da Cunha Pedrosa et al., 2010). This halts the build up of inflammation.

And since NF-κB is involved in cell survival, which works to our advantage in the acute sense, it’s clear why we find it turned on indefinitely in cancer cells. Besides melatonin, though, calorie restriction (or fasting) is one of the most effective ways to shut down NF-κB, thereby shutting down the entire inflammatory system that drives the progression of chronic and acute diseases. 

While some inflammation is actually good for us, we too often tip the scale and accumulate an excessive amount of reactive oxygen species (ROS) in our cellular environment. This is considered to give rise to an unfortunately unrecognized state plaguing our society:  underlying oxidative stress (Sies, 1997).

Fortunately for us, each cell in our body has its own internal defense mechanism to fight against oxidative stress. Chiefly, this is mediated by the transcription factor NF-E2-related factor 2 (Nrf2). If NF-κB is the master regulator of pro-inflammatory cascades, Nrf2 is the master regulator of anti-inflammatory cascades; it offers a battery of defensive mechanisms and regulates detoxification genes. Indeed, Nrf2 is stabilized and activated when ROS and electrophiles rise (Shelton & Jaiswal, 2013). 

Bottom line:  Inflammation is associated with an elevated production of cytokines and chemokines, and melatonin is associated with a reduction in those pro-inflammatory cytokines , with a concomitant elevation in the level of the anti-inflammatory cytokine IL-10 (Habtemariam et al., 2017; Hardeland, 2019). While there are a few concerns about the potential pro-inflammatory actions of melatonin when used in very high doses or under suppressed immune conditions (where it may induce an increase production of pro-inflammatory cytokines, IL-1β, IL-2, IL-6, IL-12, TNF-α, and IFN-γ) (Carrascal et al., 2018), it’s important to remember that in ALI-infection models, melatonin consistently demonstrates anti-inflammatory and protective action (Huang et al., 2010).



The Antioxidative Effect of Melatonin

Viral infections (and their replication) constantly produce oxidized products. We know this from SARS-induced acute lung injury (ALI) models, where the production of oxidized low density lipoprotein (LDL) activate the innate immune response by the overproduction of IL-6 lung (alveolar) macrophages via Toll-like receptor 4 (TLR4)/NF-kB signaling, thereby leading to ALI (Imai et al., 2008).

TLR4 is a receptor for the innate immune system, and it is also a therapeutic target for melatonin. In cerebral ischemia (when an insufficient amount of blood flows to the brain), gastritis, and periodontitis disease models, melatonin has documented anti-inflammation actions via TLR4 signaling (Luo et al., 2018; Renn et al., 2018; Zhao et al., 2019). 

The anti-oxidative effect of melatonin has also been identified in acute lung injury caused by radiation, sepsis, and ischemia-reperfusion (Chen et al., 2014; Wang et al., 2018; Wu et al., 2019). In ALI/ARDS patients, especially when this condition is advanced and in patients treated in ICUs, severe inflammation, hypoxemia, and mechanical ventilation with high oxygen concentrations increases oxidant generation locally and, inevitably, spills out to the rest of the body systematically (Sarma & Ward, 2011; Tamura et al., 2020). Melatonin could help clean a lot of this inflammatory damage up.

Melatonin’s use is not a novel idea.

Its use as a therapy has been known for well over a decade, thanks, in part, to the extensive studies conducted by Gitto and his colleagues in 2004 and 20055 (during the aftermath of the first SARS pandemic). It was this team that used melatonin to treat newborn infants with respiratory distress that found the antioxidant and anti-inflammatory actions of melatonin in the lung. Thus, the application of melatonin would likely be beneficial in controlling inflammation and oxidation in those infected with coronavirus.

 

Dr. Bhandari and the Advanced Health Team Are Here to Support Your Health.

Our expert team of integrative holistic practitioners work with patients suffering from chronic health concerns.  We help our patients reverse disease by better understanding how the body optimally functions and providing personalized treatment plans. To learn more and book an appointment, contact Advanced Health or call 1-415-506-9393.

 

References

 

Ahmadi, Z., & Ashrafizadeh, M. (2020). Melatonin as a potential modulator of Nrf2. Fundamental & clinical pharmacology, 34(1), 11-19.

 

Albensi, B. C., & Mattson, M. P. (2000). Evidence for the involvement of TNF and NF‐κB in hippocampal synaptic plasticity. Synapse, 35(2), 151-159.

 

Baltimore, D. (2009). Discovering NF-κB. Cold Spring Harbor perspectives in biology, 1(1), a000026.

 

Carrascal, L., Nunez-Abades, P., Ayala, A., & Cano, M. (2018). Role of melatonin in the inflammatory process and its therapeutic potential. Current Pharmaceutical Design, 24(14), 1563-1588.

 

Chen, H. H., Chang, C. L., Lin, K. C., Sung, P. H., Chai, H. T., Zhen, Y. Y., ... & Chen, C. H. (2014). Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury. American journal of translational research, 6(5), 439.

 

Corvo, M. L., Jorge, J. C., van't Hof, R., Cruz, M. E. M., Crommelin, D. J., & Storm, G. (2002). Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1564(1), 227-236.

 

da Cunha Pedrosa, A. M., Weinlich, R., Mognol, G. P., Robbs, B. K., de Biaso Viola, J. P., Campa, A., & Amarante-Mendes, G. P. (2010). Melatonin protects CD4+ T cells from activation-induced cell death by blocking NFAT-mediated CD95 ligand upregulation. The Journal of Immunology, 184(7), 3487-3494.

 

Gitto, E., Reiter, R. J., Cordaro, S. P., La Rosa, M., Chiurazzi, P., Trimarchi, G., ... & Barberi, I. (2004). Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. American journal of perinatology, 21(04), 209-216.

 

Gitto, E., Reiter, R. J., Sabatino, G., Buonocore, G., Romeo, C., Gitto, P., ... & Barberi, I. (2005). Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. Journal of pineal research, 39(3), 287-293.

 

Habtemariam, S., Daglia, M., Sureda, A., Selamoglu, Z., Fuat Gulhan, M., & Mohammad Nabavi, S. (2017). Melatonin and respiratory diseases: a review. Current topics in medicinal chemistry, 17(4), 467-488.

 

Hadar, A., Gozes, I., & Gurwitz, D. (2017). RGS2 and SIRT1 Link Renin Angiotensin Aldosterone System to Alzheimer’s Disease. In Neuroprotection in Alzheimer's Disease (pp. 239-251). Academic Press.

 

Hardeland, R. (2018). Melatonin and inflammation—Story of a double‐edged blade. Journal of pineal research, 65(4), e12525.

 

Hardeland, R. (2019). Aging, melatonin, and the pro-and anti-inflammatory networks. International Journal of Molecular Sciences, 20(5), 1223.

 

Huang, S. H., Cao, X. J., Liu, W., Shi, X. Y., & Wei, W. (2010). Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. Journal of pineal research, 48(2), 109-116.

 

Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., ... & Liu, H. (2008). Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell, 133(2), 235-249.

 

İnal, M. E., Kanbak, G., & Sunal, E. (2001). Antioxidant enzyme activities and malondialdehyde levels related to aging. Clinica chimica acta, 305(1-2), 75-80.

 

Kaltschmidt, B., & Kaltschmidt, C. (2009). NF-κB in the nervous system. Cold Spring Harbor perspectives in biology, 1(3), a001271.

 

Kangralkar, V. A., Patil, S. D., & Bandivadekar, R. M. (2010). Oxidative stress and diabetes: a review. International Journal of Pharmaceutical Applications, 1(1), 38-45.

 

Karin, M. (2009). NF-κB as a critical link between inflammation and cancer. Cold Spring Harbor perspectives in biology, 1(5), a000141.

 

Klaunig, J. E., Kamendulis, L. M., & Hocevar, B. A. (2010). Oxidative stress and oxidative damage in carcinogenesis. Toxicologic pathology, 38(1), 96-109.

 

Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008). HMGB1: endogenous danger signaling. Molecular medicine, 14(7-8), 476-484.

 

Landis, G. N., & Tower, J. (2005). Superoxide dismutase evolution and life span regulation. Mechanisms of ageing and development, 126(3), 365-379.

 

Ling, Y., Li, Z. Z., Zhang, J. F., Zheng, X. W., Lei, Z. Q., Chen, R. Y., & Feng, J. H. (2018). MicroRNA-494 inhibition alleviates acute lung injury through Nrf2 signaling pathway via NQO1 in sepsis-associated acute respiratory distress syndrome. Life sciences, 210, 1-8.

 

Luo, J., Song, J., Zhang, H., Zhang, F., Liu, H., Li, L., ... & Lin, M. (2018). Melatonin mediated Foxp3-downregulation decreases cytokines production via the TLR2 and TLR4 pathways in H. pylori infected mice. International immunopharmacology, 64, 116-122.

 

McCord, J. M., & Fridovich, I. (1969). Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein). Journal of Biological chemistry, 244(22), 6049-6055.

 

Mattson, M. P., Culmsee, C., Yu, Z., & Camandola, S. (2000). Roles of nuclear factor κB in neuronal survival and plasticity. Journal of neurochemistry, 74(2), 443-456.

 

Miller, A. F. (2001). Handbook of metalloproteins. Messerschmidt, A., Huber, R., Poulos, T., Wieghardt, K., Eds, 668-682.

 

Noor, R., Mittal, S., & Iqbal, J. (2002). Superoxide dismutase–applications and relevance to human diseases. Medical Science Monitor, 8(9), RA210-RA215.

 

Qin, Z. H., TAO, L. Y., & Chen, X. (2007). Dual roles of NF‐κB in cell survival and implications of NF‐κB inhibitors in neuroprotective therapy 1. Acta Pharmacologica Sinica, 28(12), 1859-1872.

 

Reiter, R. J., Ma, Q., & Sharma, R. (2020). Treatment of Ebola and other infectious diseases: melatonin “goes viral”. Melatonin Research, 3(1), 43-57.

 

Renn, T. Y., Huang, Y. K., Feng, S. W., Wang, H. W., Lee, W. F., Lin, C. T., ... & Chang, H. M. (2018). Prophylactic supplement with melatonin successfully suppresses the pathogenesis of periodontitis through normalizing RANKL/OPG ratio and depressing the TLR 4/MyD88 signaling pathway. Journal of pineal research, 64(3), e12464.

 

Salminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2008). Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing research reviews, 7(2), 83-105.

 

Sarma, J. V., & Ward, P. A. (2011). Oxidants and redox signaling in acute lung injury. Comprehensive Physiology, 1(3), 1365-1381.

 

Shang, Y., Xu, S. P., Wu, Y., Jiang, Y. X., Wu, Z. Y., Yuan, S. Y., & Yao, S. L. (2009). Melatonin reduces acute lung injury in endotoxemic rats. Chinese medical journal, 122(12), 1388.

 

Shelton, P., & Jaiswal, A. K. (2013). The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 27(2), 414–423.

 

Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Experimental Physiology: Translation and Integration, 82(2), 291-295.

 

Sun, C. K., Lee, F. Y., Kao, Y. H., Chiang, H. J., Sung, P. H., Tsai, T. H., ... & Chen, Y. L. (2015). Systemic combined melatonin–mitochondria treatment improves acute respiratory distress syndrome in the rat. Journal of Pineal Research, 58(2), 137-150.

 

Tainer, J. A., Getzoff, E. D., Richardson, J. S., & Richardson, D. C. (1983). Structure and mechanism of copper, zinc superoxide dismutase. Nature, 306(5940), 284-287.

 

Tamura, D. Y., Moore, E. E., Partrick, D. A., Johnson, J. L., Offner, P. J., & Silliman, C. C. (2002). Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock, 17(4), 269-273.

 

Tudek, B., Winczura, A., Janik, J., Siomek, A., Foksinski, M., & Oliński, R. (2010). Involvement of oxidatively damaged DNA and repair in cancer development and aging. American journal of translational research, 2(3), 254.

 

Wang, M. L., Wei, C. H., Wang, W. D., Wang, J. S., Zhang, J., & Wang, J. J. (2018). Melatonin attenuates lung ischaemia–reperfusion injury via inhibition of oxidative stress and inflammation. Interactive cardiovascular and thoracic surgery, 26(5), 761-767.

 

Wang, Q. L., Yang, L., Peng, Y., Gao, M., Yang, M. S., Xing, W., & Xiao, X. Z. (2019). Ginsenoside Rg1 regulates SIRT1 to ameliorate sepsis-induced lung inflammation and injury via inhibiting endoplasmic reticulum stress and inflammation. Mediators of inflammation, 2019.

 

Wu, R. P., Hayashi, T., Cottam, H. B., Jin, G., Yao, S., Wu, C. C., ... & Carson, D. A. (2010). Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences, 107(16), 7479-7484.

 

Wu, X., Ji, H., Wang, Y., Gu, C., Gu, W., Hu, L., & Zhu, L. (2019). Melatonin alleviates radiation-induced lung injury via regulation of miR-30e/NLRP3 Axis. Oxidative Medicine and Cellular Longevity, 2019.

 

Yasui, K., & Baba, A. (2006). Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflammation Research, 55(9), 359-363.

 

Youn, H. D., Kim, E. J., Roe, J. H., HAH, Y. C., & KANG, S. O. (1996). A novel nickel-containing superoxide dismutase from Streptomyces spp. Biochemical Journal, 318(3), 889-896.

 

Yuan, Y., Cruzat, V. F., Newsholme, P., Cheng, J., Chen, Y., & Lu, Y. (2016). Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mechanisms of ageing and development, 155, 10-21.

 

Zhao, Y., Wang, H., Chen, W., Chen, L., Liu, D., Wang, X., & Wang, X. (2019). Melatonin attenuates white matter damage after focal brain ischemia in rats by regulating the TLR4/NF-κB pathway. Brain research bulletin, 150, 168-178.

Author
Payal Bhandari M.D. Dr. Payal Bhandari M.D. Dr. Payal Bhandari M.D. is one of U.S.'s top leading integrative functional medical physicians and the founder of San Francisco' top ranked medical center, SF Advanced Health. Her well-experienced holistic healthcare team collaborates together to deliver whole-person personalized care and combines the best in Western and Eastern medicine. By being an expert of cell function, Dr. Bhandari defines the root cause of illness and is able to subside any disease within weeks to months. She specializes in cancer prevention and reversal, digestive & autoimmune disorders. Dr. Bhandari received her Bachelor of Arts degree in biology in 1997 and Doctor of Medicine degree in 2001 from West Virginia University. She the completed her Family Medicine residency in 2004 from the University of Massachusetts and joined a family medicine practice in 2005 which was eventually nationally recognized as San Francisco’s 1st patient-centered medical home. To learn more, go to www.sfadvancedhealth.com.

You Might Also Enjoy...